Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathrin Scheckenbach

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Cancer Research|March 22, 2003
Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimensVera Balz, Kathrin Scheckenbach, Karl Götte, et al.
International Journal of Cancer|August 12, 2005
Comprehensive analysis of the p53 status in mucosal and cutaneous melanomasChristian Gwosdz, Kathrin Scheckenbach, Oliver Lieven, et al.
JAMA Otolaryngology-- Head & Neck Surgery|December 5, 2014
Taking a fresh look at the skull base in otorhinolaryngology with web-based simulation: Student's Interactive Skull-Base Trainer (SISTer)Peter Freiherr von Sass, Kathrin Scheckenbach, Martin Wagenmann, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2004
p53 codon 72 polymorphic variants, loss of allele-specific transcription, and human papilloma virus 16 and/or 18 E6 messenger RNA expression in squamous cell carcinomas of the head and neckKathrin Scheckenbach, Oliver Lieven, Karl Götte, et al.
Head & Neck|September 5, 2002
Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding regionUlrich Hauser, Vera Balz, Thomas E Carey, et al.
Plos One|April 22, 2017
Diagnostic and prognostic value of long noncoding RNAs as biomarkers in urothelial carcinomaJohanna Droop, Tibor Szarvas, Wolfgang A Schulz, et al.
Journal of Negative Results in Biomedicine|December 28, 2010
The checkpointkinase 2 (CHK2) 1100delC germ line mutation is not associated with the development of squamous cell carcinoma of the head and neck (SCCHN)Kathrin Scheckenbach, Galatia Papadopoulou, Thomas K Hoffmann, et al.
Clinical and Translational Allergy|August 3, 2012
The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptomsRalf Baumann, Matthaeus Rabaszowski, Igor Stenin, et al.
American Journal of Rhinology & Allergy|July 26, 2013
Comparison of the nasal release of IL-4, IL-10, IL-17, CCL13/MCP-4, and CCL26/eotaxin-3 in allergic rhinitis during season and after allergen challengeRalf Baumann, Matthaeus Rabaszowski, Igor Stenin, et al.
Auris, Nasus, Larynx|October 28, 2009
Emerging therapeutic options in fulminant invasive rhinocerebral mucormycosisKathrin Scheckenbach, Oliver Cornely, Thomas K Hoffmann, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Cancer Research|March 22, 2003
Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimensVera Balz, Kathrin Scheckenbach, Karl Götte, et al.
International Journal of Cancer|August 12, 2005
Comprehensive analysis of the p53 status in mucosal and cutaneous melanomasChristian Gwosdz, Kathrin Scheckenbach, Oliver Lieven, et al.
JAMA Otolaryngology-- Head & Neck Surgery|December 5, 2014
Taking a fresh look at the skull base in otorhinolaryngology with web-based simulation: Student's Interactive Skull-Base Trainer (SISTer)Peter Freiherr von Sass, Kathrin Scheckenbach, Martin Wagenmann, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2004
p53 codon 72 polymorphic variants, loss of allele-specific transcription, and human papilloma virus 16 and/or 18 E6 messenger RNA expression in squamous cell carcinomas of the head and neckKathrin Scheckenbach, Oliver Lieven, Karl Götte, et al.
Head & Neck|September 5, 2002
Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding regionUlrich Hauser, Vera Balz, Thomas E Carey, et al.
Plos One|April 22, 2017
Diagnostic and prognostic value of long noncoding RNAs as biomarkers in urothelial carcinomaJohanna Droop, Tibor Szarvas, Wolfgang A Schulz, et al.
Journal of Negative Results in Biomedicine|December 28, 2010
The checkpointkinase 2 (CHK2) 1100delC germ line mutation is not associated with the development of squamous cell carcinoma of the head and neck (SCCHN)Kathrin Scheckenbach, Galatia Papadopoulou, Thomas K Hoffmann, et al.
Clinical and Translational Allergy|August 3, 2012
The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptomsRalf Baumann, Matthaeus Rabaszowski, Igor Stenin, et al.
American Journal of Rhinology & Allergy|July 26, 2013
Comparison of the nasal release of IL-4, IL-10, IL-17, CCL13/MCP-4, and CCL26/eotaxin-3 in allergic rhinitis during season and after allergen challengeRalf Baumann, Matthaeus Rabaszowski, Igor Stenin, et al.
Auris, Nasus, Larynx|October 28, 2009
Emerging therapeutic options in fulminant invasive rhinocerebral mucormycosisKathrin Scheckenbach, Oliver Cornely, Thomas K Hoffmann, et al.
Pageof 8